Form 4 for ORMP ORAMED PHARMACEUTICALS INC.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0001213900-22-008755 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-22 | 2022-02-17 | ORMP | RAKIN KEVIN | Dir | M - OptEx | $4.80 | +6,667 | 59.7K | +13% | +$32.0K |
| D | 2022-02-22 | 2022-02-17 | ORMP | RAKIN KEVIN | Dir | F - Tax | $10.63 | -3,010 | 56.7K | -5% | -$32.0K |
| D | 2022-02-22 | 2022-02-17 | ORMP | RAKIN KEVIN | Dir | M - OptEx | $0.00 | -6,667 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | M | A | 6,667 | $4.80 | 59,671 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-17 | F | D | 3,010 | $10.63 | 56,661 | D | — | — | (F1) Represents a cashless exercise of outstanding stock options to purchase 6,667 shares of common stock. The reporting person received 3,657 shares of common stock and surrendered 3,010 shares of common stock underlying the stock option in payment of the exercise price. |
| 3 | Derivative | Stock Option (right to buy) | 2022-02-17 | M | D | 6,667 | $0.00 | 0 | D | $4.80 · 2020-12-30 to 2030-01-08 | 6,667 Common Stock |